Darin Copeland

Darin Copeland is an experienced finance professional with a diverse background in various leadership roles across multiple organizations. Currently serving as Head of Finance for US Pharma at Alcon since May 2019, Darin's career includes significant positions at Alcon following its spin-off from Novartis, as well as finance management roles at Novartis and Johnson & Johnson. Darin's expertise extends from revenue accounting to supply chain reporting and analysis, with a foundational experience in auditing at KPMG and external financial reporting at ONEOK. Academic achievements include an MBA in Finance from Melbourne Business School and dual Bachelor's degrees in Accounting and Mathematics from Oklahoma Baptist University.